当前位置: X-MOL 学术Biom. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Doug Altman: Driving critical appraisal and improvements in the quality of methodological and medical research
Biometrical Journal ( IF 1.3 ) Pub Date : 2020-07-08 , DOI: 10.1002/bimj.202000053
Willi Sauerbrei 1 , Martin Bland 2 , Stephen J W Evans 3 , Richard D Riley 4 , Patrick Royston 5 , Martin Schumacher 1 , Gary S Collins 6
Affiliation  

Doug Altman was a visionary leader and one of the most influential medical statisticians of the last 40 years. Based on a presentation in the "Invited session in memory of Doug Altman" at the 40th Annual Conference of the International Society for Clinical Biostatistics (ISCB) in Leuven, Belgium and our long-standing collaborations with Doug, we discuss his contributions to regression modeling, reporting, prognosis research, as well as some more general issues while acknowledging that we cannot cover the whole spectrum of Doug's considerable methodological output. His statement "To maximize the benefit to society, you need to not just do research but do it well" should be a driver for all researchers. To improve current and future research, we aim to summarize Doug's messages for these three topics.

中文翻译:


道格·奥尔特曼:推动方法论和医学研究质量的严格评估和改进



道格·奥尔特曼 (Doug Altman) 是一位富有远见的领导者,也是过去 40 年来最有影响力的医学统计学家之一。基于在比利时鲁汶举行的国际临床生物统计学会 (ISCB) 第 40 届年会上“纪念 Doug Altman 特邀会议”中的演讲以及我们与 Doug 的长期合作,我们讨论了他对回归模型的贡献、报告、预后研究以及一些更普遍的问题,同时承认我们无法涵盖道格大量方法论成果的全部范围。他的这句话“为了最大程度地造福社会,你不仅需要做研究,而且需要把它做好”应该成为所有研究人员的动力。为了改进当前和未来的研究,我们旨在总结道格关于这三个主题的信息。
更新日期:2020-07-08
down
wechat
bug